Eusebio Gaínza

619 total citations
15 papers, 494 citations indexed

About

Eusebio Gaínza is a scholar working on Organic Chemistry, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eusebio Gaínza has authored 15 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Organic Chemistry, 3 papers in Pharmacology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eusebio Gaínza's work include Antibiotic Resistance in Bacteria (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Fatty Acid Research and Health (3 papers). Eusebio Gaínza is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Fatty Acid Research and Health (3 papers). Eusebio Gaínza collaborates with scholars based in Spain, Switzerland and Colombia. Eusebio Gaínza's co-authors include José Luís Pedraz, Miguel Viñas, Rosa Marı́a Hernández, Tania B. López-Méndez, Daniel Bachiller, Yining Xu, Ana Beloqui, Amaia Esquisabel, Marta Pastor and José Miguel Sahuquillo-Arce and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Green Chemistry and Biotechnology Advances.

In The Last Decade

Eusebio Gaínza

15 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eusebio Gaínza Spain 11 145 84 84 67 54 15 494
Abdullah A. Alshehri Saudi Arabia 16 259 1.8× 74 0.9× 83 1.0× 90 1.3× 38 0.7× 44 751
Chiung‐Hung Chang Taiwan 12 138 1.0× 139 1.7× 66 0.8× 44 0.7× 81 1.5× 16 617
Fahad A. Almughem Saudi Arabia 14 203 1.4× 57 0.7× 41 0.5× 78 1.2× 24 0.4× 30 570
Hashem Montaseri Iran 14 105 0.7× 260 3.1× 57 0.7× 92 1.4× 60 1.1× 40 698
Mahendra Singh India 16 163 1.1× 208 2.5× 42 0.5× 34 0.5× 42 0.8× 38 749
Alexandra R. Vaughn United States 17 235 1.6× 87 1.0× 139 1.7× 25 0.4× 69 1.3× 28 1.1k
Diani Meza Casa Brazil 7 137 0.9× 140 1.7× 164 2.0× 20 0.3× 41 0.8× 8 468
Waleed S. Alharbi Saudi Arabia 16 155 1.1× 219 2.6× 73 0.9× 83 1.2× 38 0.7× 35 607
Banu Mansuroğlu Türkiye 13 190 1.3× 77 0.9× 65 0.8× 17 0.3× 28 0.5× 37 652

Countries citing papers authored by Eusebio Gaínza

Since Specialization
Citations

This map shows the geographic impact of Eusebio Gaínza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eusebio Gaínza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eusebio Gaínza more than expected).

Fields of papers citing papers by Eusebio Gaínza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eusebio Gaínza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eusebio Gaínza. The network helps show where Eusebio Gaínza may publish in the future.

Co-authorship network of co-authors of Eusebio Gaínza

This figure shows the co-authorship network connecting the top 25 collaborators of Eusebio Gaínza. A scholar is included among the top collaborators of Eusebio Gaínza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eusebio Gaínza. Eusebio Gaínza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pastor, M., Xavier Gomis, Benito Almirante, et al.. (2020). In vitro and in vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC). Nanomedicine Nanotechnology Biology and Medicine. 29. 102259–102259. 17 indexed citations
2.
3.
Fleischer, Aarne, Amaia Esquisabel, José Luis Castrillo, et al.. (2020). iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation. Molecular Therapy — Methods & Clinical Development. 17. 858–870. 34 indexed citations
4.
Xu, Yining, et al.. (2020). Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis. International Journal of Pharmaceutics. 586. 119515–119515. 50 indexed citations
5.
Gaínza, Eusebio, et al.. (2020). Towards Green Nanoscience: From extraction to nanoformulation. Biotechnology Advances. 46. 107657–107657. 34 indexed citations
6.
López-Méndez, Tania B., et al.. (2020). Encapsulation of Oleuropein in Nanostructured Lipid Carriers: Biocompatibility and Antioxidant Efficacy in Lung Epithelial Cells. Pharmaceutics. 12(5). 429–429. 52 indexed citations
7.
Fleischer, Aarne, David Aguillón, Andrés Villegas, et al.. (2019). Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene. Stem Cell Research. 37. 101440–101440. 4 indexed citations
8.
Pastor, Marta, Garazi Gainza, Xavier Gomis, et al.. (2019). Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration. Nanomedicine Nanotechnology Biology and Medicine. 18. 101–111. 25 indexed citations
9.
Collantes, María, Gemma Quincoces, Silvia Villullas, et al.. (2019). Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies. International Journal of Pharmaceutics. 569. 118484–118484. 37 indexed citations
10.
Thomas, M. Carmen, Ana Fernández‐Villegas, Bartolomé Carrilero, et al.. (2019). A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection. Antimicrobial Agents and Chemotherapy. 63(10). 10 indexed citations
11.
Herrán, Enara, José Ángel Ruíz-Ortega, Teresa Morera‐Herreras, et al.. (2018). Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation. Neurobiology of Disease. 121. 252–262. 71 indexed citations
12.
Garcı́a-Honduvilla, Natalio, Alberto Cifuentes, Miguel Á. Ortega, et al.. (2018). Immuno-modulatory effect of local rhEGF treatment during tissue repair in diabetic ulcers. Endocrine Connections. 7(4). 584–594. 9 indexed citations
13.
Pastor, Marta, Amaia Esquisabel, Miguel Viñas, et al.. (2014). Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis. International Journal of Pharmaceutics. 477(1-2). 485–494. 54 indexed citations
14.
Fusté, Ester, et al.. (2013). Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa. Journal of Medical Microbiology. 62(9). 1317–1325. 41 indexed citations
15.
Sahuquillo-Arce, José Miguel, et al.. (2006). In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.. PubMed. 19(3). 252–7. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdullah A. Alshehri Breakdown of academic impact, for papers by Chiung‐Hung Chang Breakdown of academic impact, for papers by Fahad A. Almughem Breakdown of academic impact, for papers by Hashem Montaseri Breakdown of academic impact, for papers by Mahendra Singh Breakdown of academic impact, for papers by Alexandra R. Vaughn Breakdown of academic impact, for papers by Diani Meza Casa Breakdown of academic impact, for papers by Waleed S. Alharbi Breakdown of academic impact, for papers by Banu Mansuroğlu
Rankless by CCL
2026